Genetic, Microbiological and Behavioral Factors in Obesity

Recruiting Observational Study
Obesity & Overweight Obesity Genetics
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 60
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
Jan Kochanowski University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study will assess the impact of genetic markers, microbiological (microbiome) and behavioral factors on tolerance, adherence and effectiveness of dual GLP1/GIP RA in the treatment of obesity. 200 consecutive patients who meet all inclusion and none of the exclusion criteria will be enrolled.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria * Age 18-60 years * Consent to participate in the study and providing informed written consent * Overweight or obese with a BMI \>27 Exclusion criteria * Contraindications to tirzepatide use: * Type 1 or type 2 diabetes * Pregnancy or breastfeeding * Cancer * Heart failure * Ex…
Contacts

Zbigniew Siudak PI, MD, PhD

+48 41 349 6972

zbigniew.siudak@ujk.edu.pl

CONTACT